MedTrace Logo

Vaporous Hyperoxia Therapy (VHT) in the Treatment of Foot Wounds

NCT04244201 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2020-01-30

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of Vaporous Hyperoxia Therapy (VHT), previously named Misty (WTS-1000) for the treatment of chronic foot ulcers.

Conditions

  • Neuropathic Foot Ulcer
  • Foot Ulcer

Interventions

DEVICE

Vaporous Hyperoxia Therapy

1 hour of treatment, 4 times per week

Sponsors & Collaborators

  • Vaporox

    lead INDUSTRY

Principal Investigators

  • Clifford J Wolf, DPM · Wolf Podiatry

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-06
Primary Completion
2007-03-01
Completion
2007-10-04
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04244201 on ClinicalTrials.gov